Computer Programs and Systems EBITDA 2011-2025 | CPSI

Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.^[1]

EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.

EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.

However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.

Annual EBITDA Computer Programs and Systems

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-40.7 M	25.2 M	26.9 M	22.8 M	35.6 M	35.4 M	33.6 M	24.6 M	28.3 M	53.3 M	53.7 M	44.4 M	43.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
53.7 M	-40.7 M	29.8 M

Quarterly EBITDA Computer Programs and Systems

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
4.31 M	3.94 M	8.45 M	3.09 M	-1.75 M	-188 K	-4.92 M	-1.31 M	6.79 M	-	5.56 M	5.28 M	9.56 M	-	5.06 M	8.3 M	5.47 M	5.97 M	7.54 M	3.64 M	6.55 M	8.91 M	7.09 M	6.13 M	4.35 M	9.65 M	6.78 M	3.29 M	8.18 M	-18.1 M	7.57 M	5.87 M	3.95 M	4.09 M	6.67 M	7 M	1.63 M	4.6 M	6.76 M	10.2 M	8.74 M	9.36 M	16.9 M	15.9 M	12.9 M	16 M	13.6 M	14.9 M	11 M	12.4 M	12.3 M	11.6 M	9.82 M	10.5 M	11.4 M	12.7 M	9.1 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
16.9 M	-18.1 M	7 M

References

Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.

EBITDA of other stocks in the Health information services industry

Issuer	EBITDA	Price	% 24h	Market Cap	Country
Covetrus CVET	148 M	-	-	$ 2.94 B	USA
Cerner Corporation CERN	1.43 B	-	-	$ 27.9 B	USA
Accolade ACCD	-38.6 M	-	0.29 %	$ 206 M	USA
iCAD ICAD	-6.03 M	-	-	$ 102 M	USA
Castlight Health, Inc. CSLT	-5.95 M	-	-7.28 %	$ 227 M	USA
HMS Holdings Corp. HMSY	140 M	-	-	$ 3.29 B	USA
Inovalon Holdings, Inc. INOV	187 M	-	-	$ 6.37 B	USA
Change Healthcare CHNG	691 M	-	-	$ 9.03 B	USA
MTBC MTBC	23.3 M	-	-0.58 %	$ 51.7 M	USA
Evolent Health EVH	70.8 M	$ 4.13	-0.72 %	$ 387 M	USA
Health Catalyst HCAT	-28.4 M	$ 2.38	1.28 %	$ 143 M	USA
HealthStream HSTM	62.5 M	$ 23.83	-0.75 %	$ 724 M	USA
OptimizeRx Corporation OPRX	-24 M	$ 12.76	0.16 %	$ 219 M	USA
Progyny PGNY	19 M	$ 25.51	-0.23 %	$ 2.19 B	USA
Premier PINC	119 M	$ 28.26	-	$ 2.33 B	USA
Akerna Corp. KERN	-6.57 M	-	-	$ 161 M	USA
Phreesia PHR	-107 M	$ 16.81	0.18 %	$ 917 M	USA
HealthEquity HQY	271 M	$ 92.45	-0.26 %	$ 7.91 B	USA
American Well Corporation AMWL	-185 M	$ 4.59	0.66 %	$ 68.8 M	USA
Allscripts Healthcare Solutions MDRX	253 M	-	-10.39 %	$ 886 M	USA
So-Young International SY	-579 M	$ 2.8	-3.45 %	$ 222 M	China
GoodRx Holdings GDRX	135 M	$ 2.77	0.73 %	$ 1.07 B	USA
R1 RCM RCM	223 M	-	-	$ 3.81 B	USA
Omnicell OMCL	82.6 M	$ 45.78	0.46 %	$ 2.11 B	USA
1Life Healthcare ONEM	-197 M	-	-	$ 3.37 B	USA
10x Genomics TXG	-230 M	$ 16.69	1.15 %	$ 1.96 B	USA
Schrödinger SDGR	-203 M	$ 18.38	-2.29 %	$ 1.34 B	USA
NantHealth NH	-35.3 M	-	-46.64 %	$ 10.4 M	USA
NextGen Healthcare NXGN	20.8 M	-	-	$ 1.6 B	USA
Signify Health SGFY	63.3 M	-	-0.02 %	$ 7.21 B	USA
Zhongchao ZCMD	-110 K	$ 0.53	-1.34 %	$ 2.76 M	China
Streamline Health Solutions STRM	-3.18 M	-	-	$ 21.4 M	USA
Teladoc Health TDOC	-658 M	$ 7.25	0.55 %	$ 1.24 B	USA
Tabula Rasa HealthCare TRHC	-45.6 M	-	-	$ 255 M	USA
Veeva Systems VEEV	435 M	$ 223.15	-0.49 %	$ 35.8 B	USA
SCWorx Corp. WORX	-1.26 M	$ 0.2	-1.6 %	$ 292 K	USA